Peter C. Neger has more than 35 years of litigation experience in both federal and state courts, and in arbitrations and mediations. His experience covers all phases of complex litigation, including litigation avoidance counseling, trials and appeals, pre-trial discovery, and Daubert proceedings.
Currently, among other matters, Peter represents a financial technology company in actions brought by the company’s former CEO in multiple state and federal courts arising out of the former officer’s claim to control a majority of the company’s shares; owners of a large affordable housing project located in Brooklyn, N.Y., in federal and state court litigation challenging rent increase orders issued by government authorities; a financial institution alleged to have breached its fiduciary duties as corporate trustee of a revocable trust; and a bioresearch firm engaged in a dispute with a consultant arising out of the consultant’s claim to royalties under a license agreement. Peter is also pro bono counsel for a gay Jamaican man seeking asylum in the United States based upon his sexual orientation, and a Honduran teenager seeking Special Immigrant Juvenile Status in the United States.
Peter previously served as lead national counsel for a pharmaceutical manufacturer in the fen/phen diet drug litigation, involving more than 7,000 individual and class action lawsuits filed in a federal MDL and state courts throughout the United States. He was also the court-appointed defense liaison counsel in the Ephedra MDL and a member of the defendants’ coordinating counsel. Peter acted as national coordinating counsel for a manufacturer of generic methylphenidate and functioned in the same capacity in litigation involving claims that the use of a mercury-based preservative in childhood vaccines caused autism.
Peter has also represented clients in various types of real estate litigation, including partnership disputes and dissolutions, land use disputes and commercial landlord-tenant proceedings; securities fraud and class actions; civil RICO actions; foreclosure and other bank-related litigation; SEC enforcement proceedings; trademark infringement actions; and actions involving professional liability claims, sex and race discrimination claims, and alleged bankruptcy frauds.
Recognized, Product Liability Litigation – Defendants, New York, The Best Lawyers in America (2006–2024)
Recognized, Mass Tort Litigation/Class Actions – Defendants, New York, The Best Lawyers in America (2014–2020, 2024)
Recognized, Business Litigation/Civil Litigation: Defense – New York Metro Super Lawyers (2006–2018)
Recognized, Global product liability litigation, Euromoney’s Guide to the World’s Leading Product Liability Lawyers (9th edition) (2012)
Board Member (and former Board Chair), Coro New York Leadership Center
Member, Association of the Bar of the City of New York
Fellow, New York State Bar Foundation
Co-chair, American Bar Association, Litigation Section, Pharmaceutical and Medical Device Subcommittee of the Mass Tort Litigation Committee (2005–2009)
Copyright © 2023 Morgan, Lewis & Bockius LLP. All rights reserved.